Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07920354Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of luliconazole vehicle cream in tinea corporis, Tinea cruris (TC) and Tinea faciei (2 arms), sponsored by The University of Faisalabad. Primary endpoint: Dermatophytosis Area and Severity Index at 4 weeks. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07920354.